Beractant (pulmonary surfactant from natural bovine lung extr)
Prevention & treatment of resp distress syndrome (RDS) in premature infants. Prevention in premature infants <1,250 g birth wt or w/ evidence of surfactant deficiency. Rescue to treat infants w/ RDS confirmed by X-ray & requiring mechanical ventilation.
Dosage/Direction for Use
100 mg of phospholipids/kg birth wt (4 mL/kg birth wt).
Rales & moist breath sounds can occur transiently after administration. Endotracheal suctioning or other remedial action is not necessary unless clear-cut signs of airway obstruction are present. Does not require reconstitution or sonication before use.